It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.Read more on Christmas rules:&nbsp;<a href="https://bit.ly/361oNwP" rel="noopener noreferrer" target="_blank">https://bit.ly/361oNwP</a>&nbsp;|Read more on travel quarantine changes:&nbsp;<a href="https://bit.ly/371PVLG" rel="noopener noreferrer" target="_blank">https://bit.ly/371PVLG</a>&nbsp;|'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': <a href="https://bit.ly/39bzCOU" rel="noopener noreferrer" target="_blank">https://bit.ly/39bzCOU</a> |For 30 days' free access to The Telegraph:&nbsp;<a href="https://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">https://www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Coronavirus: The Latest

Has hospitality been unfairly targeted?

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.Read more on the Oxford vaccine: <a href="https://bit.ly/2UVfPet" rel="noopener noreferrer" target="_blank">https://bit.ly/2UVfPet</a> |Read more on Brexit talks:&nbsp;<a href="https://bit.ly/36V8f8Y" rel="noopener noreferrer" target="_blank">https://bit.ly/36V8f8Y</a> |Read more on the new quarantine-free list: <a href="https://bit.ly/3lMs88H" rel="noopener noreferrer" target="_blank">https://bit.ly/3lMs88H</a> |For 30 days' free access to The Telegraph: <a href="https://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">https://www.telegraph.co.uk/audio</a> |Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

How promising is Remdesivir?

After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight against Covid-19. Top of the list? Tackling misinformation.Track cases in your area:&nbsp;<a href="https://bit.ly/2Yohewr" rel="noopener noreferrer" target="_blank">https://bit.ly/2Yohewr</a>&nbsp;|Read more about the MS drug trial:&nbsp;<a href="https://bit.ly/3kB3nuM" rel="noopener noreferrer" target="_blank">https://bit.ly/3kB3nuM</a>&nbsp;|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

The five challenges facing Joe Biden

After the Pfizer vaccine breakthrough, immunologist Dr Al Edwards tells Theodora Louloudis why the hard work isn't over even once a vaccine is approved, why talk of effective immunisation before Christmas is premature and how this particular vaccine could be particularly difficult to distribute.Read more about the rise in deaths in England and Wales:&nbsp;<a href="https://bit.ly/2GLAwWw" rel="noopener noreferrer" target="_blank">https://bit.ly/2GLAwWw</a>&nbsp;|Read more about unemployment rates: <a href="https://bit.ly/3llycof" rel="noopener noreferrer" target="_blank">https://bit.ly/3llycof</a> |Read more about Welsh exams: <a href="https://bit.ly/36oNeDo" rel="noopener noreferrer" target="_blank">https://bit.ly/36oNeDo</a> |Read Sarah Newey 'We should be concerned about the 'mink virus', but not for the reasons you think': <a href="https://bit.ly/3lu966w" rel="noopener noreferrer" target="_blank">https://bit.ly/3lu966w</a>&nbsp;|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

When will the UK be vaccinated?

As Liverpool becomes England’s first city to be offered mass coronavirus testing, The Telegraph’s Health Editor Laura Donnelly tells Theodora Louloudis why the trial could offer a glimpse into the UK’s future, and why its success hinges on public co-operation.Read more the UK's R-rate:&nbsp;<a href="https://bit.ly/35YCHyB" rel="noopener noreferrer" target="_blank">https://bit.ly/35YCHyB</a> |Read more about Paris' coronavirus infection rates:&nbsp;<a href="https://bit.ly/2HXCEe4 " rel="noopener noreferrer" target="_blank">https://bit.ly/2HXCEe4 </a>|Read Ambrose Evans-Pritchard' 'Boris has my full support on lockdown 2.0 - even though I think he’s wrong': <a href="https://bit.ly/34T24Tl" rel="noopener noreferrer" target="_blank">https://bit.ly/34T24Tl</a>&nbsp;|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Could we all be tested weekly?

With just eight weeks to go until the big day, Yolanthe Fawehinmi joins Theodora Louloudis to discuss the likelihood of households being allowed to mix nationwide over the festive season. Read more about England's coronavirus infection rates: <a href="https://bit.ly/31TdwMJ" rel="noopener noreferrer" target="_blank">https://bit.ly/31TdwMJ</a>|Read more about the leaked sage documents: <a href="https://bit.ly/34GV4ZE" rel="noopener noreferrer" target="_blank">https://bit.ly/34GV4ZE</a>|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Is Christmas "cancelled"?

Millions more Britons will soon be living under tighter coronavirus restrictions, but Sadiq Khan and Sir Keir Starmer are among the Labour MPs calling for even harsher measures. They want to see a two-week national ’circuit breaker’ lockdown, but would this diminish the problem, or simply delay it? The Telegraph’s Global Health Security Correspondent Sarah Newey tells Theodora Louloudis my the move isn't a silver bullet.Read Sarah's report from Manaus: <a href="http://www.bit.ly/3diYUe9" rel="noopener noreferrer" target="_blank">www.bit.ly/3diYUe9</a> |Read more about Wales' crackdown on English visitors: <a href="https://bit.ly/3nT22lN" rel="noopener noreferrer" target="_blank">https://bit.ly/3nT22lN</a> |Read more about Germany's rise in cases: <a href="https://bit.ly/3nUEqNx" rel="noopener noreferrer" target="_blank">https://bit.ly/3nUEqNx</a> |For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Time for a two-week lockdown?

After Boris Johnson announces a new three-tier system of increasingly tough restrictions to determine England’s local lockdowns, University of London virologist Dr Elisabetta Gropelli joins Theodora Louloudis to discuss whether a focus on social interaction is enough to avoid the death rates seen over the country’s first wave.Find out what tier your area is in: <a href="https://bit.ly/2SNBOTo" rel="noopener noreferrer" target="_blank">https://bit.ly/2SNBOTo</a>|Read more about missed cancer screenings: <a href="https://bit.ly/371Y8AX" rel="noopener noreferrer" target="_blank">https://bit.ly/371Y8AX</a>|Read more about China’s mass testing: <a href="https://bit.ly/33OpDfj" rel="noopener noreferrer" target="_blank">https://bit.ly/33OpDfj</a> |Read Sarah Newey’s piece on Manaus in Brazil: <a href="https://bit.ly/3diYUe9" rel="noopener noreferrer" target="_blank">https://bit.ly/3diYUe9</a> |For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Will the three-tier system work?

After Donald Trump and his wife, Melania test positive for coronavirus, Oxford University Professor of US Politics, Adam Smith joins Theodora Louloudis to discuss how this will affect his campaign, and why - if everything goes really wrong - it could lead to a Democratic president before the votes are even counted.Read more about SNP MP Margaret Ferrier:&nbsp;<a href="https://bit.ly/3ilI4vT " rel="noopener noreferrer" target="_blank">https://bit.ly/3ilI4vT&nbsp;</a>|Read more about England's new quarantine rules:&nbsp;<a href="https://bit.ly/3cTBWK5" rel="noopener noreferrer" target="_blank">https://bit.ly/3cTBWK5</a>&nbsp;|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Donald Trump tests positive - what next?

As case numbers rise, restrictions rise too. In the wake of England’s new lockdown measures, The Telegraph’s Associate Editor, Camilla Tominey tells Theodora Louloudis whether these are merely the beginning, why Boris Johnson’s own experience of the virus is colouring his response and why she still views the PM as a libertarian leader. Read the new rules in full: <a href="https://bit.ly/2HolciE" rel="noopener noreferrer" target="_blank">https://bit.ly/2HolciE</a> |Read Camilla Tominey’s latest analysis:&nbsp;<a href="https://bit.ly/35ZrgZk" rel="noopener noreferrer" target="_blank">https://bit.ly/35ZrgZk</a> |Read more about the US death toll: <a href="https://bit.ly/2Eo9149" rel="noopener noreferrer" target="_blank">https://bit.ly/2Eo9149</a> |Read more about job cuts: <a href="https://bit.ly/3iY9R6M" rel="noopener noreferrer" target="_blank">https://bit.ly/3iY9R6M</a> |Read more about French schools: <a href="https://bit.ly/363BDLH" rel="noopener noreferrer" target="_blank">https://bit.ly/363BDLH</a> |For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

A six-month lockdown?

Cases are rising and restrictions are being reimposed, but will an increase in UK infections lead to a spike in deaths? As the WHO warns of a rise in coronavirus fatalities across Europe from October, The Telegraph's Theodora Louloudis and Global Health Security Correspondent, Sarah Newey discuss how this could play out in Britain, and whether younger sufferers and breakthroughs in treatments are enough to stop a deadly second wave. Read more about how face masks could be giving people Covid-19 immunity: <a href="https://bit.ly/2ZAqIVD" rel="noopener noreferrer" target="_blank">https://bit.ly/2ZAqIVD</a> |Read more about the Recovery trial: <a href="https://bit.ly/2E4A30s" rel="noopener noreferrer" target="_blank">https://bit.ly/2E4A30s</a>&nbsp;|Read more about public policing of the 'rule of six': <a href="https://bit.ly/2E4A30s" rel="noopener noreferrer" target="_blank">https://bit.ly/2E4A30s</a>&nbsp;|Read more about Sir Keir Starmer's isolation: <a href="https://bit.ly/3c8H8K5" rel="noopener noreferrer" target="_blank">https://bit.ly/3c8H8K5</a>&nbsp;|For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Is Britain’s death toll about to jump?

Nearly 180 vaccines are being trialled globally, but Oxford University's has been a frontrunner from the start. On Tuesday, a hitch in the road: the trial was paused in its third and final phase. Virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss the significance of the decision, and whether global collaboration is needed to speed up the search.Read more about England's new lockdown rules: <a href="https://bit.ly/2FcTaG3" rel="noopener noreferrer" target="_blank">https://bit.ly/2FcTaG3</a>&nbsp;|Read more about the rise in cases in Italy and Portugal: <a href="https://bit.ly/3ih6OGr" rel="noopener noreferrer" target="_blank">https://bit.ly/3ih6OGr</a>&nbsp;|What you can and can't do from Monday: <a href="https://bit.ly/3mcLFzN" rel="noopener noreferrer" target="_blank">https://bit.ly/3mcLFzN</a>&nbsp;|For thirty days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

What now for the Oxford vaccine?

Over five months since the public was told to work from home where possible, the Prime Minister wants Britons back at their desks. As well as concern for the economy, mental health and productivity, ministers are warning that working from home will make people more ‘vulnerable’ to being let go. Theodora Louloudis is joined by employment law solicitor, Melanie Morton to discuss the rights of employers to fire those who wish to stay home, and the rights of employees to refuse on the grounds of health, childcare, or because they simply don’t fancy it.&nbsp;Read more the UK's current local lockdowns: <a href="https://bit.ly/3b75vqT" rel="noopener noreferrer" target="_blank">https://bit.ly/3b75vqT</a> |Read more about the latest numbers of confirmed cases and deaths: <a href="https://bit.ly/2G3SrqJ" rel="noopener noreferrer" target="_blank">https://bit.ly/2G3SrqJ</a> |For a half price subscription to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Back to work or face the sack?

After months of reduced social interaction, it's hard to shake the feeling that things just don't feel the same with some of our friendships. And a new report suggests that's because they might not be. The Oxford University psychologist behind the study, Professor Robin Dunbar joins Theodora Louloudis to discuss the hindrances of virtual friendships, why physical contact strengthens relationships and the unwelcome side-effect of becoming friends with your neighbours over the lockdown.Read more about the rules for face masks in schools: <a href="https://bit.ly/2D4vYc4" rel="noopener noreferrer" target="_blank">https://bit.ly/2D4vYc4</a> |Read more where might be next for travel quarantines: <a href="https://bit.ly/3lh8v8V" rel="noopener noreferrer" target="_blank">https://bit.ly/3lh8v8V</a> |Read more about Gatwick Airport's redundancies: <a href="https://bit.ly/3jhY6HY" rel="noopener noreferrer" target="_blank">https://bit.ly/3jhY6HY</a> |For a half price subscription to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a>&nbsp;|Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a>&nbsp;|

Has the lockdown lost us friends?

The late-evening announcement that those arriving in the UK from France will soon have to quarantine for 14 days has left Britons scrambling to get home. The Telegraph’s Deputy Travel Editor, Ben Ross joins Theodora Louloudis to discuss which countries could soon be added to the UK Government’s ‘red list’, whether France is likely to impose reciprocal measures and why this is the ‘worst case scenario' for the travel industry.Read more about the latest easing of lockdown restrictions and England’s case numbers: <a href="https://bit.ly/3gYEIiH" rel="noopener noreferrer" target="_blank">https://bit.ly/3gYEIiH</a> |Watch ‘Will holidays ever be the same?’: <a href="https://bit.ly/3fYBkCS" rel="noopener noreferrer" target="_blank">https://bit.ly/3fYBkCS</a> |For 30 days' free access to The Telegraph:&nbsp;<a href="http://www.telegraph.co.uk/audio" rel="noopener noreferrer" target="_blank">www.telegraph.co.uk/audio</a> |Email:&nbsp;<a href="mailto:coronaviruspodcast@telegraph.co.uk" rel="noopener noreferrer" target="_blank">coronaviruspodcast@telegraph.co.uk</a> |

Quarantine: Which countries are next?

The latest Coronavirus news from The Telegraph’s leading journalists, with analysis of the impact on health, business and travel in the UK and beyond.

hubhopper

Coronavirus: The Latest

hubhopper